Can you tell more about the demographic of the market you...

First 7 Last

Share
Profile

Follow
EstGreg

882 Posts.

01/05/16

23:31

Post #: 17647180
Share

Originally posted by stock2016 ↑

let me start first,

I believe the stock has a future, it's a stable investment during economy uncertainty, with changing regulations in China, I would believe more investors switch to the Company due to two child policy, and the target market for this stock is in area where not many people who can afford to pay a premier for imported milk. There is a clear distinction between this stock and A2M, BAL, as the laters targeting rich individuals.

With the potential acquisition as mentioned by CEO, this will result in increased diversity in portfolio for CDC if successfully integrated to the domestic Chinese market.

The share in first week has been running really well, with the SP traded as high as 50c, the average price since listed in ASX is well above the current SP hence a GAP has to be filled.

I'm very optimistic to this share in medium term say 12-18 months given majority shares couldn't be sold due to 24 months restrictions.

I believe with better market updates that the Company is certainly looking to improve, this stock is full of potentials.

Expand

Can you tell more about the demographic of the market you mention for CDC?

CDC Price at posting: 23.5¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

AII

Inside the Depths of Panasqueira: A Legacy Carved in Rock

KGD

Kula picks up unexplored niobium play in Malawi, with surface samples logged

THL

Tourism Holdings says Liberation Day tariffs smashed US RV demand

Trump chides Powell as Goldman call for calm. The RBA must be nervous

NMG

New Murchison Gold blasts off at Crown Prince as 'better than expected' results return

DMP

Is Domino's a steal after -25% plunge?

Listen: HotCopper Wire Podcast 016 – FY25 ended up not so bad... but Trump unpause is coming

HotCopper Highlights, Week 27: G8 scalped, Domino’s drops the box, Gemlife brief hype & more

OSL

OncoSil wraps up recruitment for key pancreatic cancer trial

Week 27 Wrap: 40% China tariffs?; ASX +10% FY25; US Amazon price spike

First 7 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Can you tell more about the demographic of the market you...

Top Stories

Inside the Depths of Panasqueira: A Legacy Carved in Rock

Kula picks up unexplored niobium play in Malawi, with surface samples logged

Tourism Holdings says Liberation Day tariffs smashed US RV demand

Trump chides Powell as Goldman call for calm. The RBA must be nervous

New Murchison Gold blasts off at Crown Prince as 'better than expected' results return

Is Domino's a steal after -25% plunge?

Listen: HotCopper Wire Podcast 016 – FY25 ended up not so bad... but Trump unpause is coming

HotCopper Highlights, Week 27: G8 scalped, Domino’s drops the box, Gemlife brief hype & more

OncoSil wraps up recruitment for key pancreatic cancer trial

Week 27 Wrap: 40% China tariffs?; ASX +10% FY25; US Amazon price spike

Featured News